Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers

Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of Vixotrigine in Healthy Volunteers

Neuropathic pain affects ~ 6.9–10% of the general population and leads to loss of function, anxiety, depression, sleep disturbance, and impaired cognition. Here, we report the safety, tolerability, and pharmacokinetics of a voltage‐dependent and use‐dependent sodium channel blocker, vixotrigine, cur...

Full description

Bibliographic Details
Main Authors:	Himanshu Naik, Deb J. Steiner, Mark Versavel, Joanne Palmer, Regan Fong
Format:	Article
Language:	English
Published:	Wiley 2021-07-01
Series:	Clinical and Translational Science
Online Access:	https://doi.org/10.1111/cts.12935

Similar Items

Design of Phase 3 Studies Evaluating Vixotrigine for Treatment of Trigeminal Neuralgia
by: Kotecha M, et al.
Published: (2020-07-01)

Evaluation of the safety, tolerability, and pharmacokinetics of RO7049389 in healthy Chinese volunteers
by: Xiaojie Wu, et al.
Published: (2022-01-01)

Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
by: Lisa M. Pitchford, et al.
Published: (2020-01-01)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
by: Wattanagoon, Y, et al.
Published: (2009)

Safety, tolerability, and pharmacokinetics of single and repeat ascending doses of CHF6001, a novel inhaled phosphodiesterase-4 inhibitor: two randomized trials in healthy volunteers
by: Mariotti F, et al.
Published: (2018-10-01)

Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects
by: Courtney Tiffany, et al.
Published: (2022-09-01)

Pharmacokinetics and Tolerability of Single and Multiple Intravenous Doses of Cefotetan Disodium in Healthy Chinese Volunteers
by: Liu J, et al.
Published: (2020-02-01)

Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers
by: Mohammad Al‐Mahdi Al‐Karagholi, et al.
Published: (2021-04-01)

Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses
by: Wu GL, et al.
Published: (2015-10-01)

Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers
by: Kun-Yan Li, PhD, et al.
Published: (2014-12-01)

Safety, tolerability, and pharmacokinetics of AL-335 in healthy volunteers and hepatitis C virus-infected subjects.
by: Matthew W McClure, et al.
Published: (2018-01-01)

Single and multiple dose pharmacokinetics and tolerability of HX-1171, a novel antioxidant, in healthy volunteers
by: Kim YH, et al.
Published: (2015-03-01)

A first‐in‐human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers
by: Folke Sjöberg, et al.
Published: (2021-05-01)

Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers
by: Lulu Chen, et al.
Published: (2018-01-01)

Phase I, Single-Dose Study to Assess the Pharmacokinetics and Safety of Suramin in Healthy Chinese Volunteers
by: Wu G, et al.
Published: (2023-07-01)

Pharmacokinetics, safety of a single dose and multiple doses of voriconazole injection of two formulations, in Chinese healthy volunteers
by: Chunqi Huang, et al.
Published: (2022-12-01)

Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers.
by: Y A de Reus, et al.
Published: (2022-01-01)

Safety, tolerability, and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers
by: John S. Grundy, et al.
Published: (2020-05-01)

Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18mg tablet in healthy adult volunteers.
by: Jose Muñoz, et al.
Published: (2018-01-01)

Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
by: Sheng L, et al.
Published: (2021-03-01)

Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers
by: Islam R. Younis, et al.
Published: (2023-03-01)

Safety, Tolerability, Pharmacokinetics, Target Occupancy, and Concentration‐QT Analysis of the Novel BTK Inhibitor Evobrutinib in Healthy Volunteers
by: Andreas Becker, et al.
Published: (2020-03-01)

Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal studyResearch in context
by: Catharina G. Faber, et al.
Published: (2023-05-01)

Pharmacokinetic interactions and tolerability of rosuvastatin and ezetimibe: an open-label, randomized, multiple-dose, crossover study in healthy male volunteers
by: Kim H, et al.
Published: (2018-04-01)

Safety, Tolerability and Pharmacokinetics of Single-Dose Oral SYHA1402 in Healthy Chinese Subjects
by: Beibei Liang, et al.
Published: (2023-04-01)

Pharmacokinetics of intranasal amiloride in healthy volunteers
by: Venkata K. Yellepeddi, et al.
Published: (2023-06-01)

Pharmacokinetics of chloroquine and primaquine in healthy volunteers
by: André Daher, et al.
Published: (2022-01-01)

Safety, tolerability, and pharmacokinetics of SMT C1100, a 2‐arylbenzoxazole utrophin modulator, following single‐ and multiple‐dose administration to healthy male adult volunteers
by: Tinsley, J, et al.
Published: (2015)

Safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of BI 187004, an inhibitor of 11beta-hydroxysteroid dehydrogenase-1, in healthy male volunteers with overweight or obesity
by: Susanna Bianzano, et al.
Published: (2021-08-01)

Phase I and scintigraphy studies to evaluate safety, tolerability, pharmacokinetics, and lung deposition of inhaled GDC‐0214 in healthy volunteers
by: Rui Zhu, et al.
Published: (2022-05-01)

Safety, tolerability, and pharmacokinetics of a single ascending subcutaneous dose of GSK3772847 in healthy participants
by: Eleni Pefani, et al.
Published: (2023-04-01)

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Sotagliflozin After Multiple Ascending Doses in Chinese Healthy Subjects
by: He X, et al.
Published: (2022-09-01)

Pharmacokinetics and Endocrine Effects of an Oral Dose of D-Pinitol in Human Fasting Healthy Volunteers
by: Juan A. Navarro, et al.
Published: (2022-10-01)

Effects of rifampicin and ketoconazole on the pharmacokinetics of a single oral dose of diethylcarbamazine in healthy volunteers
by: W Ridtitid, et al.
Published: (2006-12-01)

Single Dose Study Assessing the Pharmacokinetic and Metabolic Profile of Alverine Citrate in Healthy Volunteers
by: Simona Rizea-Savu, et al.
Published: (2021-01-01)

Pharmacokinetic Properties of Single- and Multiple-Dose Pitavastatin Calcium Tablets in Healthy Chinese Volunteers
by: Zhu Luo, MD, et al.
Published: (2015-12-01)

Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants
by: Rita Humeniuk, et al.
Published: (2023-11-01)

THE PHARMACOKINETICS OF INTRAVENOUS STABLE STRONTIUM IN HEALTHY-VOLUNTEERS
by: Demoraes, M, et al.
Published: (1989)

Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
by: Shin Y, et al.
Published: (2022-12-01)

Pharmacokinetics of Oral Prulifloxacin Capsules in Healthy Volunteers
by: Jing Zou, et al.
Published: (2011-03-01)